Caption Management, LLC Omeros Corp Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	SELL	$5.07 - $7.2 $1.55 Million - $2.2 Million	-305,600 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$5.67 - $8.54 $1.48 Million - $2.24 Million	-261,900 Reduced 46.15%	305,600 $1.97 Million
Q3 2021 Nov 12, 2021	BUY	$13.4 - $16.3 $1.16 Million - $1.41 Million	86,300 Added 17.93%	567,500 $7.83 Million
Q2 2021 Aug 16, 2021	BUY	$14.81 - $19.13 $3.64 Million - $4.71 Million	246,000 Added 104.59%	481,200 $7.14 Million
Q1 2021 May 17, 2021	BUY	$14.52 - $23.53 $1.91 Million - $3.09 Million	131,200 Added 126.15%	235,200 $4.19 Million
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $812,214 - $1.22 Million	-80,100 Reduced 43.51%	104,000 $1.49 Million
Q3 2020 Nov 16, 2020	BUY	$9.57 - $21.32 $1.76 Million - $3.93 Million	184,100 New	184,100 $1.86 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.